243 related articles for article (PubMed ID: 8093499)
21. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD).
van Duijn CM; Delasnerie-Lauprêtre N; Masullo C; Zerr I; de Silva R; Wientjens DP; Brandel JP; Weber T; Bonavita V; Zeidler M; Alpérovitch A; Poser S; Granieri E; Hofman A; Will RG
Lancet; 1998 Apr; 351(9109):1081-5. PubMed ID: 9660576
[TBL] [Abstract][Full Text] [Related]
22. Variant Creutzfeldt-Jakob disease.
Ironside JW
Haemophilia; 2010 Jul; 16 Suppl 5():175-80. PubMed ID: 20590878
[TBL] [Abstract][Full Text] [Related]
23. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
[TBL] [Abstract][Full Text] [Related]
24. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures.
Hamaguchi T; Noguchi-Shinohara M; Nozaki I; Nakamura Y; Sato T; Kitamoto T; Mizusawa H; Yamada M
Neuropathology; 2009 Oct; 29(5):625-31. PubMed ID: 19659942
[TBL] [Abstract][Full Text] [Related]
25. Preclinical sporadic Creutzfeldt-Jakob disease in French blood donors: an epidemiologic model-based study.
Pillonel J; Brandel JP; Léon L; Salomon D; Haïk S; Capek I; Vaillant V; Coste J; Alpérovitch A
Transfusion; 2012 Jun; 52(6):1290-5. PubMed ID: 22128904
[TBL] [Abstract][Full Text] [Related]
26. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
[TBL] [Abstract][Full Text] [Related]
27. [Creutzfeldt-Jakob disease and transfusional risk: the point in 1998].
Laperche S
Transfus Clin Biol; 1999 Feb; 6(1):67-71. PubMed ID: 10188213
[TBL] [Abstract][Full Text] [Related]
28. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States.
Fradkin JE; Schonberger LB; Mills JL; Gunn WJ; Piper JM; Wysowski DK; Thomson R; Durako S; Brown P
JAMA; 1991 Feb; 265(7):880-4. PubMed ID: 1992185
[TBL] [Abstract][Full Text] [Related]
29. Variant Creutzfeldt-Jakob disease and blood transfusion.
Turner ML
Curr Opin Hematol; 2001 Nov; 8(6):372-9. PubMed ID: 11604578
[TBL] [Abstract][Full Text] [Related]
30. Creutzfeldt-Jakob disease in Ireland: epidemiological aspects 1980-2002.
Horan G; Keohane C; Molloy S; Howley R; Harney M; Heffernan J; McGuigan C; Hutchinson M; Brett F; Farrell M
Eur Neurol; 2004; 51(3):132-7. PubMed ID: 14988606
[TBL] [Abstract][Full Text] [Related]
31. Transfusion transmission of human prion diseases.
Zou S; Fang CT; Schonberger LB
Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
[TBL] [Abstract][Full Text] [Related]
32. Increasing mortality from Creutzfeldt-Jakob disease in England and Wales since 1979: ascertainment bias from increase in post-mortems?
Aylin P; Rooney C; Drever F; Coleman M
Popul Trends; 1996; (85):34-8. PubMed ID: 8895949
[TBL] [Abstract][Full Text] [Related]
33. [Incidence of Creutzfeldt-Jakob disease in France, 1992-1995].
Ruffié A; Delasnerie-Lauprêtre N; Brandel JP; Jaussent I; Dormont D; Laplanche JL; Hauw JJ; Richardson S; Alpérovitch A
Rev Epidemiol Sante Publique; 1997 Dec; 45(6):448-53. PubMed ID: 9496575
[TBL] [Abstract][Full Text] [Related]
34. Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob disease. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study.
Busch MP; Glynn SA; Schreiber GB
Transfusion; 1997 Oct; 37(10):996-1002. PubMed ID: 9354816
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity to biases of case-control studies on medical procedures, particularly surgery and blood transfusion, and risk of Creutzfeldt-Jakob disease.
de Pedro Cuesta J; Ruiz Tovar M; Ward H; Calero M; Smith A; Verduras CA; Pocchiari M; Turner ML; Forland F; Palm D; Will RG
Neuroepidemiology; 2012; 39(1):1-18. PubMed ID: 22777385
[TBL] [Abstract][Full Text] [Related]
36. Creutzfeldt-Jakob disease and blood transfusion.
Fernandez Lopez MJ; Van Everbroeck B; Pals P; Martin JJ; Cras P
Acta Neurol Belg; 1998 Sep; 98(3):247-51. PubMed ID: 9801705
[TBL] [Abstract][Full Text] [Related]
37. European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors.
Zerr I; Brandel JP; Masullo C; Wientjens D; de Silva R; Zeidler M; Granieri E; Sampaolo S; van Duijn C; Delasnerie-Lauprêtre N; Will R; Poser S
J Clin Epidemiol; 2000 Jul; 53(7):747-54. PubMed ID: 10941953
[TBL] [Abstract][Full Text] [Related]
38. Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: systematic review of case-control studies.
Wilson K; Code C; Ricketts MN
BMJ; 2000 Jul; 321(7252):17-9. PubMed ID: 10875826
[TBL] [Abstract][Full Text] [Related]
39. The clinical neurology and epidemiology of Creutzfeldt-Jakob disease, with special reference to iatrogenic cases.
Brown P
Ciba Found Symp; 1988; 135():3-23. PubMed ID: 3044708
[TBL] [Abstract][Full Text] [Related]
40. Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96.
Cousens SN; Zeidler M; Esmonde TF; De Silva R; Wilesmith JW; Smith PG; Will RG
BMJ; 1997 Aug; 315(7105):389-95. PubMed ID: 9277601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
